A Fortune 100 pharmaceutical organization focused on research and development
A Fortune 100 pharmaceutical company was experiencing lengthy annual and project-based budget negotiations with its internal customers after a recent large-scale merger had driven international growth. A lack of communication across the organization’s various global sites and a resistance to change from key locations was only furthering the logjam. They needed to define a new methodology for customer cost allocations and implement a new model for estimating project efforts, tracking time, and reporting information to customers.
Approach: Think + Do
To overcome the internal communication obstacles, we created a project team comprised of key colleagues from each of the global locations. The team was then further divided into two work-streams to focus on a new Cost Allocation Methodology, and a Project Estimation and Time Tracking approach. We provided guidance and expertise in defining new best practice methods for performing necessary business functions while ensuring the final approaches led to a cohesive new overall approach to business operations.
We delivered a transparent, simple, and objective Excel-based methodology for allocating customer costs. In the first year alone, the new method eliminated the need for the previously lengthy negotiations over cost allocations. We also designed a streamlined, more accurate method for estimating projects, and modified an existing web-based application to support the new approach. Our application tracked project hours, allowing the organization to report vital project information to customers in a global, cohesive manner for the first time.